Last update 10 Jan 2025
Diagnostic Green GmbH

Diagnostic Green GmbH

Subsidiary Company|
Germany
|
10-50
|
diagnosticgreen.com

Overview

Tags

Other Diseases
Small molecule drug
Fluorescent dyes

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Hemic and Lymphatic Diseases1
Neoplasms1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug1
Fluorescent dyes1
Top 5 TargetCount
STT3B(STT3 oligosaccharyltransferase complex catalytic subunit B)1

Related

1
Drugs associated with Diagnostic Green GmbH
Indocyanine Green
Target
STT3B
Mechanism
STT3B inhibitors [+1]
Active Org.
University of PennsylvaniaUniversity of Pennsylvania [+6]
Originator Org.
Akorn, Inc.Akorn, Inc.
Active Indication
Bile Duct Diseases [+22]
Inactive Indication
Brain metastases [+5]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date09 Feb 1959
1
Clinical Trials associated with Diagnostic Green GmbH
NCT05420974 / Not yet recruitingNot Applicable
Intraoperative Arthroscopic Near-infrared Fluorescence Imaging of the Vascular Perfusion of the Meniscus in Patients Treated With Meniscal Repair
100 Clinical Results associated with Diagnostic Green GmbH
Login to view more data
0 Patents (Medical) associated with Diagnostic Green GmbH
Login to view more data
100 Deals associated with Diagnostic Green GmbH
Login to view more data
100 Translational Medicine associated with Diagnostic Green GmbH
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 11 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Indocyanine Green
 ( STT3B )		Contrast agents
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free